Search

Your search keyword '"Hubbard, S"' showing total 73 results
Start Over Author "Hubbard, S" Publication Year Range More than 50 years ago
73 results on '"Hubbard, S"'

2. Sex facts for young men

Author

Hubbard, S. Dana (Samuel Dana), b. 1869. and Hubbard, S. Dana (Samuel Dana), b. 1869.

Published
1922

6. Sex facts for young boys

Author

Hubbard, S. Dana (Samuel Dana), b. 1869. and Hubbard, S. Dana (Samuel Dana), b. 1869.

Published
1922

7. Facts about motherhood

Author

Hubbard, S. Dana (Samuel Dana), b. 1869. and Hubbard, S. Dana (Samuel Dana), b. 1869.

Published
1922

18. INFECTIOUS DISEASES: THEIR ADMINISTRATIVE CONTROL IN DIFFERENT CITIES OF THE UNITED STATES

Author

HUBBARD, S. DANA

Abstract

The Department of Health of New York City, having made some changes in the rules and regulations regarding certain infectious diseases in order to be consistent with the teachings and opinions of members of the medical profession and the scientific knowledge of today, desired to ascertain the opinions of eminent sanitarians throughout the country regarding these matters.A questionnaire was therefore sent to the health authorities of sixteen of the largest cities in the United States. QUESTIONNAIRE QUESTION 1. —What procedure have you regarding persons exposed to scarlet fever and measles and who are immune by reason of having had this disease?Exclusion from place of business when connected with the sale or handling of dairy or food products.Exclusion of children from schools, it being assumed of course that the patient ill with either scarlet fever or measles is practically and efficiently quarantined. ATLANTA: A. Persons exposed to scarlet

Published
1915
Full Text
View/download PDF

21. Hearing and the Octopus Statocyst

Author

Hubbard, S. J.

Abstract

A detailed study of the anatomy of the octopus statocyst by Young (1960) seemed to indicate that, although the maintenance of equilibrium was likely to be its most important function, the possibility of its participating in the function of hearing could not be ruled out. The work described here was an attempt to test this possibility.

Published
1960
Full Text
View/download PDF

24. INDUSTRIAL ANTHRAX

Author

Smyth, Henry Field, primary, Cheney, V. S., additional, Hubbard, S. Dana, additional, and Osborn, Stanley H., additional

Published
1926
Full Text
View/download PDF

29. BURIED LOVE.

Author

HUBBARD, S. WILLIAM

Published
1859

38. Obituaries.

Author

ALLEN, C. F., W. W. M., J., MASON, C. C., HUBBARD, S., MARINER, M. C., O. C., WITHAM, A. H., BENTON, J. T., ROBINSON, J. B., and EDSON, EDW.

Published
1872

39. Chemotherapy of advanced ovarian carcinoma: a prospective randomized comparison of phenylalanine mustard and high dose cyclophosphamide.

Author

Young RC, Canellos GP, Chabner BA, Schein PS, Hubbard SP, and DeVita VT Jr

Subjects
Administration, Oral, Cyclophosphamide administration & dosage, Dose-Response Relationship, Drug, Female, Humans, Injections, Intravenous, Laparoscopy, Melphalan administration & dosage, Ovarian Neoplasms epidemiology, Ovarian Neoplasms mortality, Remission, Spontaneous, United States, Adenocarcinoma drug therapy, Adenocarcinoma, Mucinous drug therapy, Cyclophosphamide therapeutic use, Cystadenocarcinoma drug therapy, Melphalan therapeutic use, Ovarian Neoplasms drug therapy
Abstract

Twenty-four fully staged, previously untreated patients with advanced ovarian carcinoma were prospectively randomized to either intensive intravenous cyclophosphamide or conventional oral Melphalan therapy. The median durations of initial remissions (5 and 6 mo) and the median durations of survival (15 and 14 mo) were similar for the two regimens but the toxicity of the intensive regimen was excessive. Followup indicates that long term disease free survivals are possible in those patients who achieve complete remissions on chemotherapy alone as three of the four patients achieving complete remission in the present study remain free of disease with a median survival in excess of 30 mo. High dose intensive alkylating agent therapy in the manner used in the present study fails to enhance the response to chemotherapy and produces unacceptable toxicity.

Published
1974
Full Text
View/download PDF

40. High-dose intermittent intravenous infusion of procarbazine (NSC-77213).

Author

Chabner BA, Sponzo R, Hubbard S, Canellos GP, Young RC, Schein PS, and Devita VT

Subjects
Bone Marrow drug effects, Clinical Trials as Topic, Dose-Response Relationship, Drug, Humans, Injections, Intravenous, Nausea chemically induced, Nervous System Diseases chemically induced, Procarbazine adverse effects, Procarbazine blood, Procarbazine toxicity, Time Factors, Vomiting chemically induced, Neoplasm Metastasis drug therapy, Procarbazine therapeutic use
Published
1973

44. Treatment of Hodgkin's disease and other cancers with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).

Author

Marsh JC, DeConti RC, and Hubbard SP

Subjects
Adenocarcinoma drug therapy, Adenoma, Islet Cell drug therapy, Adolescent, Adrenal Gland Neoplasms drug therapy, Adult, Breast Neoplasms drug therapy, Carcinoma, Squamous Cell drug therapy, Carmustine adverse effects, Carmustine therapeutic use, Clinical Trials as Topic, Colonic Neoplasms drug therapy, Evaluation Studies as Topic, Female, Gastrointestinal Neoplasms drug therapy, Glioblastoma drug therapy, Hemorrhage chemically induced, Humans, Leukemia, Lymphoid drug therapy, Lymphoma, Large B-Cell, Diffuse drug therapy, Male, Melanoma drug therapy, Middle Aged, Ovarian Neoplasms drug therapy, Sarcoma drug therapy, Sarcoma, Ewing drug therapy, Stomach Neoplasms drug therapy, Thrombocytopenia chemically induced, Tongue Neoplasms drug therapy, Alkylating Agents therapeutic use, Hodgkin Disease drug therapy, Neoplasms drug therapy, Nitroso Compounds therapeutic use, Urea therapeutic use
Published
1971

45. The AK tie bar.

Author

Hubbard S

Subjects
Child, Child, Preschool, Ectromelia physiopathology, Female, Hip physiopathology, Humans, Leg, Muscles physiopathology, Prosthesis Design, Artificial Limbs, Gait
Published
1972

50. Treatment of advanced neoplastic disease with 1-(2-chlorethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037).

Author

DeConti RC, Hubbard SP, Pinch P, and Bertino JR

Subjects
Adolescent, Adult, Aged, Brain Neoplasms drug therapy, Child, Child, Preschool, Female, Gastrointestinal Neoplasms drug therapy, Humans, Lymphoma drug therapy, Male, Middle Aged, Neoplasms diagnosis, Nitrosourea Compounds adverse effects, Nitrosourea Compounds blood, Neoplasms drug therapy, Nitrosourea Compounds therapeutic use
Published
1973

Catalog

Books, media, physical & digital resources
See catalog results